We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+11.65%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$864B
AUM Growth
+$69.1B
Cap. Flow
-$8.04B
Cap. Flow %
-0.93%
Top 10 Hldgs %
26.18%
Holding
2,679
New
185
Increased
873
Reduced
1,330
Closed
90

Top Buys

Rank Stock Value
1
MTCH icon
Match Group
MTCH
+$3.17B
2
NKE icon
Nike
NKE
+$1.94B
3
BAC icon
Bank of America
BAC
+$1.84B
4
FDX icon
FedEx
FDX
+$1.78B
5
PNC icon
PNC Financial Services
PNC
+$1.61B

Top Sells

Rank Stock Value
1
PPLI
People Inc
PPLI
+$4.1B
2
FTV icon
Fortive
FTV
+$2.54B
3
LIN icon
Linde
LIN
+$1.53B
4
BABA icon
Alibaba
BABA
+$1.35B
5
WTW icon
Willis Towers Watson
WTW
+$1.13B

Sector Composition

Rank Sector Weight
1 Technology 25.61%
2 Healthcare 16.74%
3 Consumer Discretionary 15.8%
4 Financials 11.46%
5 Communication Services 10.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICPT
2626
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-420,459
Closed -$20.1M
BLU
2627
DELISTED
BELLUS Health Inc.
BLU
– –
-992,997
Closed -$10.2M
DBD
2628
DELISTED
Diebold Nixdorf Incorporated
DBD
– –
-15,365
Closed -$93K
OTIC
2629
DELISTED
Otonomy, Inc.
OTIC
– –
-18,700
Closed -$68K
PHAS
2630
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
– –
-535,315
Closed -$2.46M
NTUS
2631
DELISTED
Natus Medical Inc
NTUS
– –
-19,756
Closed -$431K
DCUE
2632
DELISTED
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
– –
-215,413
Closed -$21.8M
XENT
2633
DELISTED
Intersect ENT, Inc
XENT
– –
-813,691
Closed -$11M
HBP
2634
DELISTED
Huttig Building Products, Inc.
HBP
– –
-40,446
Closed -$45K
CXP
2635
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
– –
-10,529
Closed -$138K
TRIL
2636
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-512,407
Closed -$4.14M
CBL
2637
DELISTED
CBL& Associates Properties, Inc.
CBL
– –
-173,500
Closed -$47K
RST
2638
DELISTED
ROSETTA STONE INC
RST
– –
-2,311,712
Closed -$39M
AIMT
2639
DELISTED
Aimmune Therapeutics
AIMT
– –
-5,274,902
Closed -$88.1M
MNK
2640
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-39,643
Closed -$106K
PRNB
2641
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
– –
-1,907,436
Closed -$114M
WUBA
2642
DELISTED
58.com Inc
WUBA
– –
-8,669,738
Closed -$468M
ZN
2643
DELISTED
Zion Oil & Gas, Inc.
ZN
– –
-117,600
Closed -$35K
LOGM
2644
DELISTED
LogMein, Inc.
LOGM
– –
-29,761
Closed -$2.52M
CCH.U
2645
DELISTED
Collier Creek Holdings Units, each consisting of one Class A ordinary share, $0.0001 par value, and
CCH.U
– –
-5,160,362
Closed -$74.7M
FSCT
2646
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
– –
-12,171
Closed -$258K
TLRD
2647
DELISTED
Tailored Brands, Inc.
TLRD
– –
-100,700
Closed -$94K
GCAP
2648
DELISTED
Gain Capital Holdings, Inc.
GCAP
– –
-62,224
Closed -$375K
DNR
2649
DELISTED
Denbury Resources, Inc.
DNR
– –
-209,039
Closed -$58K
NE
2650
DELISTED
Noble Corporation
NE
– –
-448,800
Closed -$144K
103 104 105
106
107

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates's Q3 2020 Portfolio in Review

As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
  • T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
  • T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
  • T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
  • T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
  • T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.

Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.